You have had type 2 diabetes for more than ten years. You have taken the medications, kept the appointments and watched your A1c move on one lab report after another, and you are still not as well managed as anyone hoped. You pay around $600 a month for insurance, and in all that time no clinician has sat down with you and explained how your numbers fit together. When a membership practice offers to do exactly that, the first question is a practical one: what happens if GoodLife Health does not accept you?
The short answer is that you get your money back. The path has four steps: an eligibility check, the intake, the checkout, and then a clinician's review. At checkout, $598 is charged to cover your first two months. If the clinician cannot accept you into care, that $598 is refunded in full. If you are accepted, those first two months are non-refundable. The rest of this piece explains why the review exists, what each outcome means for your money and your care, and who should not apply at all.
- If the clinician cannot accept you into care, the $598 charged at checkout is refunded in full; once accepted, the first two months are non-refundable.
- The order is the eligibility check, the intake, the checkout, then a clinician's review.
- A no leaves your insurance and your current clinician as they were, because the membership pairs with insurance and never replaces it.
- If accepted, you pay $299 a month, month to month after the first two months, with four lab panels a year and every result in your hands.
- Medication goes to the pharmacy you choose at that pharmacy's price, under that pharmacy's own return and refund policy.
- No one can promise you weight loss, remission or a cure, and this membership does not.
Ten years in, and wary of one more closed door
Most people in your position did not get here through neglect. A diagnosis more than a decade ago usually starts with one medication and advice about diet. A second medication follows, perhaps a third, each one added at a visit that ended before your questions did. The guide to what a direct primary care membership includes puts the average traditional primary care appointment at 18 minutes. Spread across ten years, that is a long run of short conversations, most of them about a single number.
That pattern leaves out the whole picture. Your A1c is read at one visit, your cholesterol at another, your blood pressure at a third, and your weight comes up, if it comes up at all, as something to work on. No one draws the lines between those results or tells you what the pattern means for the decade ahead. You have plenty of results. What you have never had is someone who sat with you and explained them as one system.
Meanwhile the cost has been steady. Around $600 a month goes to your premium before any deductible or copay. That coverage is real when something serious happens, and you would not want to be without it. The routine part, where a clinician manages a chronic condition with you month after month, has been the weakest thing your money has bought.
So a practice built around labs and a named clinician sounds like what you have been missing, and it also raises a defensive question. The system has let you down in small ways many times, and applying to a practice that might turn you away feels like volunteering for one more of those moments. The order of the steps makes the worry sharper. You pay at checkout, and the clinician's review comes afterward, which means handing over $598 before anyone has said yes.
There is a quieter worry under that one. After a decade of not being well managed, it is easy to assume you are the difficult case a practice would rather not take. That assumption deserves a straight answer, and so does the money.
Why a practice reviews you before taking you on
Insurance-based primary care rarely turns anyone away in this sense. A practice paid per visit grows by adding patients, and the same guide puts a typical traditional panel at 1,500 to 2,500 people per clinician, with clinicians in fee-for-service practices seeing 20 to 25 patients a day to cover overhead. Getting onto a panel like that is seldom the hard part. Getting time with the clinician who holds it is.
That arithmetic explains much of your last ten years. When a day holds that many visits, each visit handles what fits inside it: the A1c is high, so a dose goes up or a medication is added. Explaining how your lipids, blood pressure, weight and glucose relate to one another takes time the schedule does not have. The schedule had no room for the explanation, and the billing never paid for it.
Direct primary care works the other way around. The practice is paid by membership, so it keeps its panels smaller; the guide gives a typical range of 300 to 600 patients and makes clear that smaller panels are what make same-day access and longer visits sustainable. A practice run this way has to decide whom it can serve well, because every patient it takes on draws on a fixed amount of clinical time.
Practices also differ in scope. Some offer general primary care. GoodLife Health is precision direct primary care for cardiometabolic optimization: diagnosis first, then treatment, then the long haul, with labs first. Care runs through telehealth, with asynchronous messaging with the care team, video visits and four cardiometabolic lab panels a year. The review asks whether what you need fits that scope and that way of working.
Type 2 diabetes is a cardiometabolic condition, so your diagnosis sits close to the center of what this practice does. That does not decide the review by itself, and nothing here is a promise that you will be accepted. The clinician reads your whole intake and makes a clinical judgment. What Is GoodLife Health? describes how the platform supports that work: Cassandra, the software layer, organizes intake and surfaces lab trends, but she supports the clinician and does not diagnose or prescribe. A licensed person makes the decision.
Acceptance is a clinical decision made by a licensed clinician after reading the full intake. Baseline labs come before any GLP-1 or hormone protocol, because a protocol built without them is a guess.
The order of the steps follows from all this. The eligibility check comes first, before the intake and before any payment, so it is the earliest point at which a mismatch can show up. The intake gives the clinician what is needed to judge fit. The checkout comes before the review, so a clinician's time goes to people who have decided they want the care. The full refund for anyone the clinician cannot accept is what makes that order fair to you; for anyone who is accepted, the first two months are non-refundable.
It also helps to be clear about what a no would mean. It would be a judgment about whether this practice, with this scope and this model, is the right place for your care. It would say nothing about your worth as a patient. Good care happens in many places, and a clinician who tells you the fit is wrong is doing part of the job a clinician is supposed to do.
A practice that accepts everyone who pays has not looked closely at anyone.
What happens to your money and your care, either way
There are two outcomes, and it helps to see them side by side.
Your $598 and your care, by outcome
| Outcome | Your money | Your care |
|---|---|---|
| The clinician cannot accept you | The $598 is refunded in full | Your insurance and current clinician are unchanged |
| The clinician accepts you | The first two months are non-refundable; then $299 a month, month to month | Membership care begins alongside your insurance |
| Medication, if prescribed | Billed by the pharmacy you choose, under its own return and refund policy | Prescribed only when clinically indicated |
If you are not accepted
If the clinician cannot accept you into care, the $598 charged at checkout is refunded in full; had you been accepted, the first two months would have been non-refundable. The real cost of a no is the time it took to complete the eligibility check and the intake. Nothing else about your situation changes. The membership pairs with insurance for catastrophic coverage and replaces the primary-care relationship, never the insurance, so applying never asked you to give up the plan you pay around $600 a month for. Your current clinician, your prescriptions and your pharmacy stay where they were. For the same reason, do not cancel or change your insurance while you wait for an answer, or after you get one.
If you are accepted
If the clinician accepts you, the first two months, already paid at checkout, are non-refundable. After that the membership is $299 a month, month to month, which is $3,588 a year. That money comes in addition to your premium, because your insurance stays for what a membership does not cover: the guide lists hospital admissions, emergency room care, specialist visits and imaging as separate costs. The membership fee is generally eligible for HSA or FSA pre-tax dollars, which helps if you have one of those accounts.
For that fee you get clinicians licensed in all fifty states, four cardiometabolic lab panels a year, every result in your hands, asynchronous messaging with the care team, and video visits. For someone who has never had the whole picture explained, the quarterly labs are the heart of it. Results arrive four times a year, a clinician reads them together, and the numbers stay with you. A year of that shows a trend where you used to see a snapshot.
Baseline labs come before any GLP-1 or hormone protocol, so the early part of membership is about measuring before deciding. The fee is the same whatever medication is indicated and whatever the dose. There is no molecule upcharge and no dose upcharge, so the price of your care never depends on what ends up being prescribed.
Where your medication fits
Medication is unbundled from the membership. When a clinician judges a medication indicated, it is prescribed to the pharmacy you choose, at that pharmacy's own price. GoodLife Health sets nothing, sees nothing and takes nothing on medication. Only branded, FDA-approved medication is prescribed: for GLP-1 that means Wegovy, Zepbound, Mounjaro or Ozempic, and any FDA-approved medication a clinician judges indicated can be sent to your pharmacy. Medication billed by a pharmacy follows that pharmacy's own return and refund policy, which is separate from the membership's.
Whether your insurance covers a given medication is between you, your plan and the pharmacy, and it is never promised. Prior authorization is the pharmacy's process; GoodLife Health does not run it, speed it up or win it. If you pay out of pocket, the manufacturers publish their own self-pay prices. As published in September 2026, NovoCare lists Wegovy pens at $199 a month for the first two fills, an introductory offer for new patients through December 2026, and $349 a month after that, with the Wegovy pill from $149 a month at lower doses. LillyDirect lists Zepbound vials at $299 to $449 a month depending on dose. The manufacturers set those prices, and no one can promise in advance that a particular medication will be right for you.
What the membership does not do
It does not replace your insurance. It does not promise that any medication will be covered or that prior authorization will succeed. And it makes no promise about outcomes: no guaranteed weight loss, no promised remission of your diabetes, no cure. What it offers is a clinician who orders the labs, reads them as one picture, explains them to you and manages your care over time. Whether that changes your numbers is something only the work itself can show.
Is it worth applying?
The downside of applying is small and known in advance. If the answer is no, you lose the time spent on the check and the intake, the $598 comes back in full, and your coverage is untouched. If the answer is yes, the first two months are non-refundable, and from the third month on the membership runs month to month at $299.
The better question is whether you want what an accepted patient gets: a clinician who orders your labs every quarter, reads your glucose, lipids and the rest as one picture, and explains it to you. After more than a decade of results read one at a time, that is the specific thing on offer. If you want it, the review is a reasonable step, and a no would tell you something true about fit rather than something unkind about you.
Before you start, gather your current medication list and any recent lab results; the guide calls these helpful rather than required. Keep your insurance and your current clinician in place until you know the outcome. Then begin with the eligibility check, which comes before you pay anything.
Who this is not for
If you are looking for the cheapest way to get a GLP-1 prescription, this is not the practice for you. GoodLife Health sits between the $20,000-a-year concierge practice and the $99-a-month compounded app, and it says so. It never prescribes compounded GLP-1; the FDA has published its concerns about unapproved GLP-1 drugs used for weight loss, and a clinician's license carries the responsibility for what is prescribed. If a $99 app is what you want, the membership will be more than you were looking for, and you should not apply.
It is also not for someone who wants a guarantee. If you need to be told in advance that you will lose a certain amount of weight, come off a medication or reach remission, no honest clinician can tell you that, and this one will not. It is not for anyone hoping to drop their insurance, because the membership was never built to replace it. And it is not for someone who wants a specific drug promised before a clinician has seen the labs; the prescription follows the review and the results, never the other way around.
Related Reading
- What Is GoodLife Health? Direct Primary Care, Explained (2026)
- What Does Direct Primary Care Include in 2026
References
- NovoCare Pharmacy — Wegovy self-pay pricing (Novo Nordisk). 2026. www.novocare.com/pharmacy/wegovy.html
- Zepbound Self Pay Journey Program — LillyDirect vial pricing (Eli Lilly). 2026. zepbound.lilly.com/savings
- FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss (U.S. Food and Drug Administration). 2025. www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss